Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | PPARD | Q03181 | 7/20 | 0.54 |
| ▸ | PPARA | Q07869 | 7/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2575619 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL2345376 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL336842 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL1333784 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL4285232 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL347119 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL2483372 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL22612557 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL22612553 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL22612525 | 1.00 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4294375-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | Lonza Sales AG (CH) | 2023-12-27 | — | — | EP | claimed |
| CN-117177739-A | Method for loading extracellular vesicles | 隆萨销售股份有限公司 | 2023-12-05 | — | — | CN | claimed |
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | CODIAK BIOSCIENCES, INC. (US) | 2022-11-10 | — | — | US | claimed |
| WO-2022178147-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | CODIAK BIOSCIENCES, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| CN-114728078-A | Extracellular vesicles linked to molecules and uses thereof | 科迪亚克生物科学公司 | 2022-07-08 | — | — | CN | claimed |
| EP-4013457-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | Codiak BioSciences, Inc. (US) | 2022-06-22 | — | — | EP | claimed |
| WO-2021030777-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | CODIAK BIOSCIENCES, INC. (US) | 2021-02-18 | — | — | WO | claimed |
| US-20200347412-A1 | PRODUCTION OF MACROCYCLIC KETONES IN RECOMBINANT HOSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-11-05 | — | — | US | claimed |
| EP-2120586-B1 | ADJUVANTS AND METHODS OF USING THEM | ARCHER DANIELS MIDLAND CO (US) | 2018-07-04 | — | — | EP | claimed |
| EP-2560606-B1 | COLOURING COMPOSITION | KAO GERMANY GMBH (DE) | 2017-08-23 | — | — | EP | claimed |
| WO-2011131563-A1 | COLOURING COMPOSITION | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2011-10-27 | — | — | WO | claimed |
| WO-2011131562-A1 | COLOURING COMPOSITION | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2011-10-27 | — | — | WO | claimed |
| US-20100048929-A1 | METHOD FOR PRODUCING CROSS-COUPLING COMPOUND | KAO CORPORATION (JP) | 2010-02-25 | — | — | US | claimed |
| CN-101646643-A | Method for producing cross-coupled compound | KAO CORP JP | 2010-02-10 | — | — | CN | claimed |
| EP-2143705-A1 | METHOD FOR PRODUCING CROSS-COUPLING COMPOUND | Kao Corporation (JP) | 2010-01-13 | — | — | EP | claimed |
| EP-2120586-A2 | ADJUVANTS AND METHODS OF USING THEM | Archer-Daniels-Midland Company (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008100896-A2 | ADJUVANTS AND METHODS OF USING THEM | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| US-20080194410-A1 | acidificers propionic acid, methyl acetic acid, acetic acid, lactic acid, fumaric acid, citric acid, phosphoric acid mixed with lecithin emulsifier; nonphenolic nonionic surfactant such as ethoxylated monolycerides, fatty acid ethoxylates, polyoxyethylene alkyl ethers, polyoxyethylene alkyl esters; water | ARCHER DANIELS MIDLAND COMPANY | 2008-08-14 | — | — | US | claimed |
| WO-2007012980-A1 | TOBACCO WITH AN INCREASED LEVEL OF NATURAL TAR DILUTENTS | PHILIP MORRIS PRODUCTS S.A. (CH) | 2007-02-01 | — | — | WO | claimed |
| US-20060283469-A1 | Tobacco with an increased level of natural tar diluents | PHILIP MORRIS USA INC. (US) | 2006-12-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | EXOSC5, EXOSC4, EXOSC10 | FFAR4 4548/4885FFAR1 4317/4885ALDH1A1 2475/4885 |
| US-20100048929-A1 | METHOD FOR PRODUCING CROSS-COUPLING COMPOUND | FASN, ELOVL3, ELOVL1 | FFAR4 18/4885FFAR1 13/4885ALDH1A1 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.